BiopharmaTrend.com

Kymera Therapeutics

Kymera Therapeutics

Private company
KYMERA THERAPEUTICS

Kymera Therapeutics is pioneering a transformative new approach to treating previously untreatable diseases. We are advancing the field of targeted protein degradation, accessing the body’s innate protein recycling machinery to degrade rather than inhibit dysregulated, disease-causing proteins. Powered by a proprietary predictive modeling capability and a game-changing integrated degradation platform with a novel small molecule modality, our company is committed to accelerating drug discovery with an unmatched ability to target and degrade the most intractable of proteins, and advance new treatment options for patients.


Founded
2017
Status
Private company
Geography
United States of America based
Funding
$95 M
Patents
8
Research papers
6

Products

No products posted yet

Services

No services posted yet


This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality

Go to home page